Dopamine transporter imaging in neurodegenerative movement disorders: PET vs. SPECT
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2281-7565
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dopamine transporter imaging in neurodegenerative movement disorders: PET vs. SPECT ; volume:8 ; number:5 ; day:15 ; month:9 ; year:2020 ; pages:349-356 ; date:10.2020
Clinical and translational imaging ; 8, Heft 5 (15.9.2020), 349-356, 10.2020
- Urheber
-
Kerstens, Vera S.
Varrone, A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40336-020-00386-w
- URN
-
urn:nbn:de:101:1-2020120419353498363909
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kerstens, Vera S.
- Varrone, A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT
Quantitative Intensity Harmonization of Dopamine Transporter SPECT Images Using Gamma Mixture Models
Influence of CT-based attenuation correction on dopamine transporter SPECT with [123I]FP-CIT
Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools
Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion
Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT
Quantitative Intensity Harmonization of Dopamine Transporter SPECT Images Using Gamma Mixture Models
Influence of CT-based attenuation correction on dopamine transporter SPECT with [123I]FP-CIT
Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools
Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion
Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT
Quantitative Intensity Harmonization of Dopamine Transporter SPECT Images Using Gamma Mixture Models
Influence of CT-based attenuation correction on dopamine transporter SPECT with [123I]FP-CIT
Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools
Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion